Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-20

FDA Approved: DONEPEZIL HYDROCHLORIDE — Supplemental Application (Edenbridge Pharmaceuticals LLC.)

View source ↗

Summary

The FDA approved a supplemental application for donepezil hydrochloride from Edenbridge Pharmaceuticals LLC., a generic treatment for Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Donepezil hydrochloride (Donepezil hydrochloride)

Snippet

SUPPL AP for DONEPEZIL HYDROCHLORIDE (DONEPEZIL HYDROCHLORIDE)